title: Enhanced phosphorylation of p53 by ATM in response to DNA damage.
abstract: The ATM protein, encoded by the gene responsible for the human genetic disorder ataxia telangiectasia (A-T), regulates several cellular responses to DNA breaks. ATM shares a phosphoinositide 3-kinase-related domain with several proteins, some of them protein kinases. A wortmannin-sensitive protein kinase activity was associated with endogenous or recombinant ATM and was abolished by structural ATM mutations. In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage. This activity was markedly enhanced within minutes after treatment of cells with a radiomimetic drug; the total amount of ATM remained unchanged. Various damage-induced responses may be activated by enhancement of the protein kinase activity of ATM.
authors.affiliation: Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Banin
authors.forename: L
authors.initials: L
authors.lastname: Moyal
authors.forename: S
authors.initials: S
authors.lastname: Shieh
authors.forename: Y
authors.initials: Y
authors.lastname: Taya
authors.forename: C W
authors.initials: CW
authors.lastname: Anderson
authors.forename: L
authors.initials: L
authors.lastname: Chessa
authors.forename: N I
authors.initials: NI
authors.lastname: Smorodinsky
authors.forename: C
authors.initials: C
authors.lastname: Prives
authors.forename: Y
authors.initials: Y
authors.lastname: Reiss
authors.forename: Y
authors.initials: Y
authors.lastname: Shiloh
authors.forename: Y
authors.initials: Y
authors.lastname: Ziv
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000730:Androstadienes / Q000494:pharmacology; D001260:Ataxia Telangiectasia / Q000378:metabolism; D064007:Ataxia Telangiectasia Mutated Proteins; D002352:Carrier Proteins; D018797:Cell Cycle Proteins; D002460:Cell Line; D004249:DNA Damage; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D009154:Mutation; D019869:Phosphatidylinositol 3-Kinases / Q000737:chemistry; D010750:Phosphoproteins / Q000378:metabolism; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000737:chemistry / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases; D011506:Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D025521:Tumor Suppressor Proteins; D000077191:Wortmannin; D009353:Zinostatin / Q000494:pharmacology
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000730:Androstadienes; D064007:Ataxia Telangiectasia Mutated Proteins; D002352:Carrier Proteins; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D019869:Phosphatidylinositol 3-Kinases; D010750:Phosphoproteins; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D011506:Proteins; D011994:Recombinant Proteins; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; D000077191:Wortmannin; D009353:Zinostatin; C087000:EIF4EBP1 protein, human; C576324:ATM protein, human